FMR CORP 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Ascendis Pharma A/S ASND |
FMR CORP | 5,114,369 9.067% |
-114,701 (-2.19%) |
Filing |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Ascendis Pharma A/S ASND |
FMR CORP | 5,229,070 9.271% |
-126,873 (-2.37%) |
Filing |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Ascendis Pharma A/S ASND |
FMR CORP | 5,355,943 9.496% |
-19,180 (-0.36%) |
Filing |
| 2021-05-10 1:11 pm Purchase |
2021-05-07 | 13G | Ascendis Pharma A/S ASND |
FMR CORP | 5,375,123 10.000% |
33,514 (+0.63%) |
Filing |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | Ascendis Pharma A/S ASND |
FMR CORP | 5,341,609 9.999% |
-120 (-0.00%) |
Filing |
| 2020-12-10 09:15 am Purchase |
2020-12-09 | 13G | Ascendis Pharma A/S ASND |
FMR CORP | 5,341,729 10.000% |
567,776 (+11.89%) |
Filing |